PD Dr. Jan Dörrie

Department of Dermatology

CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges. (2019) Harrer D, Dörrie J, Schaft N Journal article, Review article Curatopes Melanoma: A Database of Predicted T-cell Epitopes from Overly Expressed Proteins in Metastatic Cutaneous Melanoma. (2019) Lischer C, Eberhardt M, Jaitly T, Schinzel C, Schaft N, Dörrie J, Schuler G, Vera González J Journal article Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance. (2019) Wiesinger M, Maerz J, Kummer M, Schuler G, Dörrie J, Schuler-Thurner B, Schaft N Journal article Vaccination with dendritic Cells for metastasized Uveal Melanoma: immunological and clinical Responses (2019) Moreira A, Gross S, Uslu U, Dörrie J, Kummer M, Schliep S, Sponagl F, et al. Conference contribution CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia (2019) Harrer DC, Schuler G, Dörrie J, Schaft N Journal article The transfection of natural killer T cells with a tumor-antigen specific chimeric antigen receptor (CAR) for melanoma immunotherapy (2019) Simon B, Wiesinger M, Maerz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution Autophagic degradation of lamins facilitates the nuclear egress of herpes simplex virus type 1 (2019) Turan A, Grosche L, Krawczyk A, Mühl-Zürbes P, Drassner C, Düthorn A, Kummer M, et al. Journal article The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma (2018) Simon B, Harrer DC, Schuler-Thurner B, Schaft N, Schuler G, Dörrie J, Uslu U Journal article Chimeric Antigen Receptors in Different Cell Types: New Vehicles Join the Race. (2018) Harrer DC, Dörrie J, Schaft N Journal article, Review article BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy (2018) Dörrie J, Babalija L, Hoyer S, Gerer KF, Schuler G, Heinzerling L, Schaft N Journal article